Omniactive announces investment from TA Associates

Published: 12-Jan-2021

Founder and Executive Chairman Sanjaya Mariwala has also increased his personal holding

OmniActive Health Technologies has announced TA Associates has acquired a significant stake in the company.

Omniactive offers natural ingredients it says are scientifically-validated for dietary supplementation and nutritional fortification. It works with human nutrition brands and manufacturers globally, and has R&D and manufacturing operations in Pune, Hosur and Thane in India; along with sales and distribution operations in the US, Europe, India, Asia, Australia and Latin America.

"We are pleased to welcome TA Associates as a strategic investor and partner for the next phase of OmniActive's growth journey. We believe that TA has deep capabilities and experience investing in companies focused on nutritional ingredients, and shares OmniActive's vision of bringing innovative, natural and science-based solutions to our customers and end consumers. We intend to leverage our strong management capabilities and TA's distinctive M&A sourcing engine to drive programmatic M&A and in-licensing to continuously deliver innovation to our customers," said Sanjaya Mariwala, founder, Executive Chairman and MD of OmniActive.

"We believe that the nutritional ingredients space will see strong growth over the next decade. OmniActive has built a strong reputation and deep customer relationships by focusing on natural, R&D-led innovative ingredients. We look forward to working together with Mr Mariwala and the OmniActive management team to further accelerate the growth in this business through organic levers and M&A," said Naresh Patwari, a Director at TA Associates Advisory Private Limited.

"We believe that TA's global healthcare experience will be valuable in supporting OmniActive's next phase of growth through continued organic growth and strategic acquisitions. OmniActive has been growing at an accelerated pace, driven by a portfolio of branded, innovative natural products with clinically supported health benefits, and we are excited to continue this growth journey and supporting our customers with TA as our new equity partner," said Jim Hamilton, CEO of OmniActive.

You may also like